Cotton Bone Filler
2025-07-15 06:50:40

Japan Stryker Launches Advanced Cotton Bone Filler for Treating Bone Irregularities

Introduction to CBF: The Cotton Bone Filler



Japan Stryker Co., based in Shinjuku, Tokyo, is set to launch its new product, Cotton Bone Filler (CBF), in July 2025. This revolutionary artificial bone filler is designed to address irregular bone defects resulting from fractures in limbs. The product has been developed under a manufacturing contract with ORTHOREBIRTH Co. located in Yokohama, Kanagawa. The flexibility and adaptability of CBF are aimed at meeting the clinical needs of orthopedic specialists across Japan.

Features of Cotton Bone Filler



The CBF has a unique, fibrous cotton-like structure that allows for shape adjustment beyond what traditional block or granule bone fillers can provide. This feature is critical, especially when it comes to treating crushing fractures that create uneven spaces between bone fragments. CBF can be inserted precisely into gaps, enhancing operational efficiency for surgeons.

One of the most significant advantages of CBF is its ability to retain blood and bone marrow fluids, which is essential for creating an ideal environment for bone regeneration. Unlike conventional fillers, which may not integrate well with the existing bone structure, CBF is gradually absorbed in the body and replaced with bone tissue over time. This property makes CBF a suitable alternative for cases where autogenous bone grafting is challenging.

Moreover, the product can be combined with chipped bone — intentionally reduced to a fine state — to amplify the filling capacity, thereby expanding its range of applications. This capability is particularly beneficial for elderly patients with diminished bone regenerative abilities.

Implementation in Clinical Settings



The CBF filler is anticipated to be utilized alongside other implants, including the recently released Variac II distal radius locking plate, which debuted in June 2025. By complementing traditional implants with this innovative filling material, Japan Stryker aims to improve treatment outcomes for fracture cases considerably.

This strategic move underscores Japan Stryker’s commitment to addressing the specific needs of healthcare providers in Japan by providing comprehensive solutions. The company is actively pursuing partnerships within Japan to enhance its product portfolio and deliver high-quality medical care.

About Japan Stryker Co.



Japan Stryker operates as the Japanese arm of Stryker Corporation, headquartered in Michigan, USA. Known as a global leader in medical technology, Stryker collaborates closely with healthcare professionals to advance the field of medicine. They offer innovative devices and services across various sectors, including surgical equipment, neurotechnology, orthopedics, and spinal-related fields. Stryker contributes to the health of more than 150 million patients annually worldwide. For more information, visit www.stryker.com/jp.

Regulatory Information


  • - Manufacturer: ORTHOREBIRTH Co.
  • - Commercial Name: Revosys-JS
  • - Medical Device Approval Number: 30300BZX00095A05

Conclusion



With the planned introduction of CBF, Japan Stryker is poised to revolutionize the treatment of bone injuries. By continuing to refine its product offerings and expand collaborations, the company seeks to uplift the quality of healthcare across Japan, ensuring that many patients benefit from advanced medical solutions.


画像1

画像2

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.